<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Considerable progress has been achieved in recent years in treating children affected by <z:e sem="disease" ids="C0005940" disease_type="Disease or Syndrome" abbrv="">bone diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Advances in the understanding of the molecular pathophysiology of genetic <z:e sem="disease" ids="C0005940" disease_type="Disease or Syndrome" abbrv="">bone diseases</z:e> have led to the development of enzyme replacement therapies for various <z:e sem="disease" ids="C0085078" disease_type="Disease or Syndrome" abbrv="">lysosomal storage diseases</z:e>, following the breakthrough initiated in treating <z:e sem="disease" ids="C0017205" disease_type="Disease or Syndrome" abbrv="">Gaucher disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical studies are underway with tailored molecules correcting <z:hpo ids='HP_0002659'>bone fragility</z:hpo> and alleviating <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002653'>bone pain</z:hpo> and other manifestations of <z:e sem="disease" ids="C0020630" disease_type="Disease or Syndrome" abbrv="">hypophosphatasia</z:e>, or promoting growth of long bones in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>We further report our very encouraging experience with intravenous bisphosphonate treatment in children suffering from secondary <z:hpo ids='HP_0000938'>osteopenia</z:hpo> and the high prevalence of calcium and <z:chebi fb="27" ids="27300">vitamin D</z:chebi> deficits in these severely disabled children </plain></SENT>
</text></document>